Inter‐Institutional Dynamics and Impact of Fluconazole‐Resistant Candida parapsilosis
Mycoses · 2025
DOI: 10.1111/myc.70017 ↗Kurz gefasst
Fachartikel in der Zeitschrift Mycoses, 2025. Verfasst von Maya Korem und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Microbiology and Infectious Diseases, Hadassah Medical Center, Jerusalem, Israel. Hauptthemen laut MEDLINE: Fluconazole, Drug Resistance, Fungal, Candida parapsilosis, Antifungal Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: Israeli Science Foundation, Bridging fund of Hadassah Medical Center.
Abstract (Originalsprache)
Background
Infections with fluconazole‐resistant Candida parapsilosis have been increasing in Israeli hospitals with unclear implications for patient outcomes.
Objectives
To determine the frequency, mechanisms, molecular epidemiology, and outcomes of azole‐resistant C. parapsilosis bloodstream infections in four hospitals in Israel. Patients/Methods C. parapsilosis bloodstream isolates were collected at four hospitals in central Israel during varying periods from 2005 to 2022. Antifungal susceptibility testing was done using CLSI broth microdilution. Risk factors for fluconazole resistance were investigated using logistic regression. ERG11 gene sequencing was performed on all isolates. Genetic relatedness was determined using multilocus microsatellite genotyping. Clinical cure, microbiological eradication, and mortality rates were compared between fluconazole‐susceptible and resistant isolates.
Results
A total of 192 patient‐specific C. parapsilosis isolates were analysed. Resistance to fluconazole and voriconazole was detected in 80 (41%) and 14 (7.2%) isolates, respectively. The ERG11 Y132F substitution was found in 91% of fluconazole‐resistant and 1% of fluconazole‐susceptible isolates. Increasing age, intensive care hospitalisation, haemodialysis, and recent exposure to antibiotics were risk factors for fluconazole‐resistant C. parapsilosis . Distinct but related genotypes predominated at each centre, indicating extensive dissemination within hospitals and limited transmission among them. Fluconazole resistance was associated with increased likelihood of microbiological failure but no significant difference in clinical cure and mortality.
Conclusions
We found high rates of fluconazole resistance in C. parapsilosis , attributable to nosocomial spread of hospital‐specific clones bearing the Y132F substitution. Fluconazole resistance was associated with a higher risk of microbiological but not clinical failure. Strategies to limit nosocomial transmission of C. parapsilosis are needed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Microbiology and Infectious Diseases, Hadassah Medical Center, Jerusalem, Israel.
- Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
- Infectious Diseases Unit, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
- School of Medicine, Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel.
- Infectious Diseases Unit and Laboratories, Sheba Medical Center, Ramat Gan, Israel.
- Infectious Diseases Unit, Rabin Medical Center, Beilinson Hospital, Petah-Tikva, Israel.
ORCID-Profile: Maya Korem
Förderung
- Israeli Science Foundation
- Bridging fund of Hadassah Medical Center
Zitieren
APA
Korem, M., Reich, S., Rahav, G., Yahav, D., Weinberger, M., Novikov, A., Mizrahi, N., & Ben-Ami, R. (2025). Inter‐Institutional Dynamics and Impact of Fluconazole‐Resistant Candida parapsilosis. Mycoses. https://doi.org/10.1111/myc.70017
Vancouver
Korem M, Reich S, Rahav G, Yahav D, Weinberger M, Novikov A, et al. Inter‐Institutional Dynamics and Impact of Fluconazole‐Resistant Candida parapsilosis. Mycoses. 2025. doi:10.1111/myc.70017
BibTeX
@article{Korem2025,
author = {Korem, Maya and Reich, Shelly and Rahav, Galia and Yahav, Dafna and Weinberger, Miriam and Novikov, Anna and Mizrahi, Naama and Ben-Ami, Ronen},
title = {Inter‐Institutional Dynamics and Impact of Fluconazole‐Resistant Candida parapsilosis},
journal = {Mycoses},
year = {2025},
doi = {10.1111/myc.70017}
}
EUVIMED